The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
The Extent And Impact Of Pharmaceutical Opioids For Chronic Non-cancer Pain
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
There have been dramatic increases in the use of pharmaceutical opioids (PO) for chronic non-cancer pain (CNCP), despite limited data on their long-term effectiveness and an increase in associated harm. This Fellowship provides critical new data to inform both clinicians and policymakers on the global extent of PO for CNCP, trajectories of problematic use and associated morbidity and a unique evaluation of the impact of real-time prescription monitoring program to reduce these harms.
Determining The Impact Of Pharmaceutical Opioid Use In Australia: A Focus On Burden, Risks And Harms
Funder
National Health and Medical Research Council
Funding Amount
$320,891.00
Summary
Despite a dramatic increase in opioid use in Australia and increasing concern about this issue, there are few detailed and robust data on the magnitude of opioid use in the community, and the characteristics of those at risk of adverse outcomes. This program of work will produce unique population-level evidence about the burden, risks and health consequences of opioid use in Australia, to better inform future policies and interventions regarding opioid prescribing to improve clinical outcomes.
Evaluating The Effectiveness Of Future Tobacco Control Strategies
Funder
National Health and Medical Research Council
Funding Amount
$368,112.00
Summary
This research will evaluate promising new strategies to reduce the harm caused by tobacco, the leading preventable cause of premature death in Australia. This includes evaluation of general population-based strategies, such as public smoking bans, and interventions to help smokers quit smoking, such as new cessation aids and long-term maintenance on pharmaceutical nicotine or low-nitrosamine smokeless tobacco.
Pharmaceutical Opioid Analgesic (POA) Dependence And Treatment Responses
Funder
National Health and Medical Research Council
Funding Amount
$390,628.00
Summary
Dependence on opioid based pain medication is a rapidly growing health concern in Australia. In the United States more people die each year from misusing pain medication than from using illicit drugs like heroin. Dr Suzanne Nielsen, an emerging expert in pharmaceutical misuse, will undertake essential research to understand the dependence to opioid pain medication in Australia and to develop appropriate treatment responses.
Maximising Treatment Participation Among Heroin Users Released From Prison
Funder
National Health and Medical Research Council
Funding Amount
$320,580.00
Summary
People who use heroin commonly spend time in prison. Contact with treatment services after release from prison is important for reducing the risk that released heroin users will return to regular drug use. However, we know that few heroin users enter or are retained in treatment after release from prison. This project aims to examine how opioid pharmacotherapy in prison affects the probability that someone will enter, and stay in, treatment after they are released from prison.
Examination Of The Trajectories And Health Consequences Of Pharmaceutical Opioid Use In Australia
Funder
National Health and Medical Research Council
Funding Amount
$316,449.00
Summary
The profile of illicit opioid use in Australia has shifted over the past decade, with fewer new heroin users and substantial increases in extra-medical pharmaceutical opioid use. This Fellowship utilises longitudinal and health surveillance data to examine pharmaceutical opioid use and health consequences among growing and hidden populations. It will provide important new evidence for how best to improve the prescribing of pharmaceutical opioids and respond to illicit opioid use.
Interventions To Improve Outcomes For Young Aboriginal And Torres Strait Islander People In Sexually Transmissible Infections Blood Borne Viruses And For People Using Methamphetamines
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
This ECF will enable research to be carried out in the domains of sexually transmissible infections (STI) and blood borne viruses (BBV) and specifically methamphetamine (MA) use in Aboriginal communities nationally. Specific research outcomes will be the establishment of an Aboriginal primary health care and behavioural surveillance network for STIs/BBVs in nationally dispersed clinical hubs (CRE), and an improved understanding of interventions to address MA in Aboriginal communities.